Effects  ||| S:0 E:8 ||| NNS
of  ||| S:8 E:11 ||| IN
competitive  ||| S:11 E:23 ||| JJ
and  ||| S:23 E:27 ||| CC
noncompetitive  ||| S:27 E:42 ||| JJ
showjumping  ||| S:42 E:54 ||| NN
on  ||| S:54 E:57 ||| IN
total  ||| S:57 E:63 ||| JJ
and  ||| S:63 E:67 ||| CC
free  ||| S:67 E:72 ||| JJ
iodothyronines ||| S:72 E:86 ||| NN
,  ||| S:86 E:88 ||| ,
β-endorphin ||| S:88 E:99 ||| NNP
,  ||| S:99 E:101 ||| ,
ACTH  ||| S:101 E:106 ||| NNP
and  ||| S:106 E:110 ||| CC
cortisol  ||| S:110 E:119 ||| JJ
levels  ||| S:119 E:126 ||| NNS
of  ||| S:126 E:129 ||| IN
horses  ||| S:129 E:136 ||| NNS
Limited  ||| S:136 E:144 ||| JJ
knowledge  ||| S:144 E:154 ||| NN
exists  ||| S:154 E:161 ||| VBZ
about  ||| S:161 E:167 ||| IN
the  ||| S:167 E:171 ||| DT
differentiated  ||| S:171 E:186 ||| JJ
effects  ||| S:186 E:194 ||| NNS
of  ||| S:194 E:197 ||| IN
competitive  ||| S:197 E:209 ||| JJ
and  ||| S:209 E:213 ||| CC
noncompetitive  ||| S:213 E:228 ||| JJ
showjumping  ||| S:228 E:240 ||| NN
on  ||| S:240 E:243 ||| IN
thyroid  ||| S:243 E:251 ||| JJ
function  ||| S:251 E:260 ||| NN
and  ||| S:260 E:264 ||| CC
relationships  ||| S:264 E:278 ||| NNS
with  ||| S:278 E:283 ||| IN
hypothalamic-hypophysis-corticoadrenal  ||| S:283 E:322 ||| JJ
hormones ||| S:322 E:330 ||| NNS
.  ||| S:330 E:332 ||| .
To  ||| S:332 E:335 ||| TO
obtain  ||| S:335 E:342 ||| VB
preliminary  ||| S:342 E:354 ||| JJ
data  ||| S:354 E:359 ||| NNS
about  ||| S:359 E:365 ||| IN
differentiated  ||| S:365 E:380 ||| JJ
effects  ||| S:380 E:388 ||| NNS
of  ||| S:388 E:391 ||| IN
competitive  ||| S:391 E:403 ||| JJ
and  ||| S:403 E:407 ||| CC
noncompetitive  ||| S:407 E:422 ||| JJ
showjumping  ||| S:422 E:434 ||| NN
on  ||| S:434 E:437 ||| IN
total  ||| S:437 E:443 ||| JJ
and  ||| S:443 E:447 ||| CC
free  ||| S:447 E:452 ||| JJ
iodothyronines ||| S:452 E:466 ||| NN
,  ||| S:466 E:468 ||| ,
β-endorphin ||| S:468 E:479 ||| NNP
,  ||| S:479 E:481 ||| ,
ACTH  ||| S:481 E:486 ||| NNP
and  ||| S:486 E:490 ||| CC
cortisol  ||| S:490 E:499 ||| NN
of  ||| S:499 E:502 ||| IN
horses ||| S:502 E:508 ||| NNS
.  ||| S:508 E:510 ||| .
Five  ||| S:510 E:515 ||| CD
trained  ||| S:515 E:523 ||| JJ
healthy  ||| S:523 E:531 ||| JJ
jumper  ||| S:531 E:538 ||| JJ
horses  ||| S:538 E:545 ||| NNS
were  ||| S:545 E:550 ||| VBD
studied  ||| S:550 E:558 ||| VBN
during  ||| S:558 E:565 ||| IN
competitive  ||| S:565 E:577 ||| JJ
and  ||| S:577 E:581 ||| CC
noncompetitive  ||| S:581 E:596 ||| JJ
showjumping ||| S:596 E:607 ||| NN
,  ||| S:607 E:609 ||| ,
performed  ||| S:609 E:619 ||| VBN
in  ||| S:619 E:622 ||| IN
the  ||| S:622 E:626 ||| DT
same  ||| S:626 E:631 ||| JJ
circuit  ||| S:631 E:639 ||| NN
design  ||| S:639 E:646 ||| NN
over  ||| S:646 E:651 ||| IN
10  ||| S:651 E:654 ||| CD
fences  ||| S:654 E:661 ||| NNS
of  ||| S:661 E:664 ||| IN
1.10  ||| S:664 E:669 ||| CD
m ||| S:669 E:670 ||| NNS
.  ||| S:670 E:672 ||| .
Hormone  ||| S:672 E:680 ||| JJ
levels  ||| S:680 E:687 ||| NNS
before ||| S:687 E:693 ||| RB
,  ||| S:693 E:695 ||| ,
5  ||| S:695 E:697 ||| CD
and  ||| S:697 E:701 ||| CC
30  ||| S:701 E:704 ||| CD
min  ||| S:704 E:708 ||| JJ
post  ||| S:708 E:713 ||| NN
exercise  ||| S:713 E:722 ||| NN
were  ||| S:722 E:727 ||| VBD
recorded ||| S:727 E:735 ||| VBN
.  ||| S:735 E:737 ||| .
Serum  ||| S:737 E:743 ||| JJ
iodothyronines  ||| S:743 E:758 ||| NN
and  ||| S:758 E:762 ||| CC
cortisol  ||| S:762 E:771 ||| JJ
concentrations  ||| S:771 E:786 ||| NNS
were  ||| S:786 E:791 ||| VBD
measured  ||| S:791 E:800 ||| VBN
in  ||| S:800 E:803 ||| IN
duplicate  ||| S:803 E:813 ||| FW
utilising  ||| S:813 E:823 ||| FW
EIA  ||| S:823 E:827 ||| FW
kits ||| S:827 E:831 ||| FW
.  ||| S:831 E:833 ||| .
Serum  ||| S:833 E:839 ||| NNP
ACTH  ||| S:839 E:844 ||| NNP
and  ||| S:844 E:848 ||| CC
plasma  ||| S:848 E:855 ||| JJ
β-endorphin  ||| S:855 E:867 ||| JJ
concentrations  ||| S:867 E:882 ||| NNS
were  ||| S:882 E:887 ||| VBD
analysed  ||| S:887 E:896 ||| VBN
in  ||| S:896 E:899 ||| IN
duplicate  ||| S:899 E:909 ||| FW
utilising  ||| S:909 E:919 ||| FW
RIA  ||| S:919 E:923 ||| FW
kits ||| S:923 E:927 ||| FW
.  ||| S:927 E:929 ||| .
Two-way  ||| S:929 E:937 ||| NNP
RM  ||| S:937 E:940 ||| NNP
ANOVA  ||| S:940 E:946 ||| NNP
was  ||| S:946 E:950 ||| VBD
applied  ||| S:950 E:958 ||| VBN
to  ||| S:958 E:961 ||| TO
test  ||| S:961 E:966 ||| VB
for  ||| S:966 E:970 ||| IN
effects  ||| S:970 E:978 ||| NNS
of  ||| S:978 E:981 ||| IN
interaction  ||| S:981 E:993 ||| NN
between  ||| S:993 E:1001 ||| IN
different  ||| S:1001 E:1011 ||| JJ
type  ||| S:1011 E:1016 ||| NN
of  ||| S:1016 E:1019 ||| IN
session  ||| S:1019 E:1027 ||| NN
and  ||| S:1027 E:1031 ||| CC
time ||| S:1031 E:1035 ||| NN
.  ||| S:1035 E:1037 ||| .
Significant  ||| S:1037 E:1049 ||| JJ
differences  ||| S:1049 E:1061 ||| NNS
between  ||| S:1061 E:1069 ||| IN
post  ||| S:1069 E:1074 ||| NN
exercise  ||| S:1074 E:1083 ||| NN
and  ||| S:1083 E:1087 ||| CC
basal  ||| S:1087 E:1093 ||| JJ
values  ||| S:1093 E:1100 ||| NNS
were  ||| S:1100 E:1105 ||| VBD
established  ||| S:1105 E:1117 ||| VBN
using  ||| S:1117 E:1123 ||| VBG
Bonferroni ||| S:1123 E:1133 ||| NNP
's  ||| S:1133 E:1136 ||| POS
multiple  ||| S:1136 E:1145 ||| JJ
comparison  ||| S:1145 E:1156 ||| NN
test ||| S:1156 E:1160 ||| NN
.  ||| S:1160 E:1162 ||| .
A  ||| S:1162 E:1164 ||| DT
linear  ||| S:1164 E:1171 ||| JJ
correlation  ||| S:1171 E:1183 ||| NN
analysis  ||| S:1183 E:1192 ||| NN
( ||| S:1192 E:1193 ||| -LRB-
Pearson ||| S:1193 E:1200 ||| NNP
's  ||| S:1200 E:1203 ||| POS
method ||| S:1203 E:1209 ||| NN
)  ||| S:1209 E:1211 ||| -RRB-
was  ||| S:1211 E:1215 ||| VBD
performed  ||| S:1215 E:1225 ||| VBN
to  ||| S:1225 E:1228 ||| TO
analyse  ||| S:1228 E:1236 ||| VB
the  ||| S:1236 E:1240 ||| DT
relationships  ||| S:1240 E:1254 ||| NNS
between  ||| S:1254 E:1262 ||| IN
total  ||| S:1262 E:1268 ||| JJ
and  ||| S:1268 E:1272 ||| CC
free  ||| S:1272 E:1277 ||| JJ
iodothyronines  ||| S:1277 E:1292 ||| NN
and  ||| S:1292 E:1296 ||| CC
between  ||| S:1296 E:1304 ||| IN
iodothyronines  ||| S:1304 E:1319 ||| NN
and  ||| S:1319 E:1323 ||| CC
β-endorphin ||| S:1323 E:1334 ||| JJ
,  ||| S:1334 E:1336 ||| ,
ACTH  ||| S:1336 E:1341 ||| NNP
and  ||| S:1341 E:1345 ||| CC
cortisol ||| S:1345 E:1353 ||| NN
.  ||| S:1353 E:1355 ||| .
In  ||| S:1355 E:1358 ||| IN
sampling  ||| S:1358 E:1367 ||| JJ
times  ||| S:1367 E:1373 ||| NNS
adopted  ||| S:1373 E:1381 ||| VBD
no  ||| S:1381 E:1384 ||| DT
statistical  ||| S:1384 E:1396 ||| JJ
different  ||| S:1396 E:1406 ||| JJ
effects  ||| S:1406 E:1414 ||| NNS
of  ||| S:1414 E:1417 ||| IN
type  ||| S:1417 E:1422 ||| NN
of  ||| S:1422 E:1425 ||| IN
session  ||| S:1425 E:1433 ||| NN
were  ||| S:1433 E:1438 ||| VBD
recorded  ||| S:1438 E:1447 ||| VBN
on  ||| S:1447 E:1450 ||| IN
hormone  ||| S:1450 E:1458 ||| NN
variables ||| S:1458 E:1467 ||| NNS
.  ||| S:1467 E:1469 ||| .
Sampling  ||| S:1469 E:1478 ||| JJ
time  ||| S:1478 E:1483 ||| NN
affected  ||| S:1483 E:1492 ||| VBD
ACTH  ||| S:1492 E:1497 ||| NNP
( ||| S:1497 E:1498 ||| -LRB-
F  ||| S:1498 E:1500 ||| NNP
=  ||| S:1500 E:1502 ||| SYM
4.25 ||| S:1502 E:1506 ||| CD
;  ||| S:1506 E:1508 ||| :
P  ||| S:1508 E:1510 ||| NN
< ||| S:1510 E:1512 ||| SYM
0.02 ||| S:1512 E:1516 ||| CD
)  ||| S:1516 E:1518 ||| -RRB-
and  ||| S:1518 E:1522 ||| CC
T ||| S:1522 E:1523 ||| NN
( ||| S:1523 E:1524 ||| -LRB-
4 ||| S:1524 E:1525 ||| LS
)  ||| S:1525 E:1527 ||| -RRB-
( ||| S:1527 E:1528 ||| -LRB-
F  ||| S:1528 E:1530 ||| NNP
=  ||| S:1530 E:1532 ||| SYM
4.43 ||| S:1532 E:1536 ||| CD
;  ||| S:1536 E:1538 ||| :
P  ||| S:1538 E:1540 ||| NN
< ||| S:1540 E:1542 ||| SYM
0.02 ||| S:1542 E:1546 ||| CD
)  ||| S:1546 E:1548 ||| -RRB-
post  ||| S:1548 E:1553 ||| NN
exercise  ||| S:1553 E:1562 ||| NN
changes ||| S:1562 E:1569 ||| NNS
.  ||| S:1569 E:1571 ||| .
During  ||| S:1571 E:1578 ||| IN
the  ||| S:1578 E:1582 ||| DT
noncompetitive  ||| S:1582 E:1597 ||| JJ
session ||| S:1597 E:1604 ||| NN
,  ||| S:1604 E:1606 ||| ,
significant  ||| S:1606 E:1618 ||| JJ
correlations  ||| S:1618 E:1631 ||| NN
existed  ||| S:1631 E:1639 ||| VBD
between  ||| S:1639 E:1647 ||| IN
T ||| S:1647 E:1648 ||| NN
( ||| S:1648 E:1649 ||| -LRB-
4 ||| S:1649 E:1650 ||| LS
)  ||| S:1650 E:1652 ||| -RRB-
and  ||| S:1652 E:1656 ||| CC
β-endorphin  ||| S:1656 E:1668 ||| NNP
( ||| S:1668 E:1669 ||| -LRB-
r  ||| S:1669 E:1671 ||| LS
=  ||| S:1671 E:1673 ||| SYM
-0.56 ||| S:1673 E:1678 ||| CD
) ||| S:1678 E:1679 ||| -RRB-
,  ||| S:1679 E:1681 ||| ,
ACTH  ||| S:1681 E:1686 ||| NNP
( ||| S:1686 E:1687 ||| -LRB-
r  ||| S:1687 E:1689 ||| LS
=  ||| S:1689 E:1691 ||| SYM
-0.65 ||| S:1691 E:1696 ||| CD
) ||| S:1696 E:1697 ||| -RRB-
,  ||| S:1697 E:1699 ||| ,
between  ||| S:1699 E:1707 ||| IN
β-endorphin  ||| S:1707 E:1719 ||| JJ
and  ||| S:1719 E:1723 ||| CC
ACTH  ||| S:1723 E:1728 ||| NNP
( ||| S:1728 E:1729 ||| -LRB-
r  ||| S:1729 E:1731 ||| LS
=  ||| S:1731 E:1733 ||| SYM
0.52 ||| S:1733 E:1737 ||| CD
)  ||| S:1737 E:1739 ||| -RRB-
and  ||| S:1739 E:1743 ||| CC
between  ||| S:1743 E:1751 ||| IN
T ||| S:1751 E:1752 ||| NN
( ||| S:1752 E:1753 ||| -LRB-
3 ||| S:1753 E:1754 ||| LS
)  ||| S:1754 E:1756 ||| -RRB-
and  ||| S:1756 E:1760 ||| CC
fT ||| S:1760 E:1762 ||| NNP
( ||| S:1762 E:1763 ||| -LRB-
3 ||| S:1763 E:1764 ||| LS
)  ||| S:1764 E:1766 ||| -RRB-
( ||| S:1766 E:1767 ||| -LRB-
r  ||| S:1767 E:1769 ||| LS
=  ||| S:1769 E:1771 ||| SYM
0.72 ||| S:1771 E:1775 ||| CD
) ||| S:1775 E:1776 ||| -RRB-
;  ||| S:1776 E:1778 ||| :
during  ||| S:1778 E:1785 ||| IN
competition  ||| S:1785 E:1797 ||| NN
between  ||| S:1797 E:1805 ||| IN
β-endorphin  ||| S:1805 E:1817 ||| JJ
and  ||| S:1817 E:1821 ||| CC
T ||| S:1821 E:1822 ||| NN
( ||| S:1822 E:1823 ||| -LRB-
3 ||| S:1823 E:1824 ||| LS
)  ||| S:1824 E:1826 ||| -RRB-
( ||| S:1826 E:1827 ||| -LRB-
r  ||| S:1827 E:1829 ||| LS
=  ||| S:1829 E:1831 ||| SYM
-0.67 ||| S:1831 E:1836 ||| CD
) ||| S:1836 E:1837 ||| -RRB-
,  ||| S:1837 E:1839 ||| ,
fT ||| S:1839 E:1841 ||| NNP
( ||| S:1841 E:1842 ||| -LRB-
3 ||| S:1842 E:1843 ||| LS
)  ||| S:1843 E:1845 ||| -RRB-
( ||| S:1845 E:1846 ||| -LRB-
r  ||| S:1846 E:1848 ||| LS
=  ||| S:1848 E:1850 ||| SYM
-0.59 ||| S:1850 E:1855 ||| CD
) ||| S:1855 E:1856 ||| -RRB-
.  ||| S:1856 E:1858 ||| .
These  ||| S:1858 E:1864 ||| DT
preliminary  ||| S:1864 E:1876 ||| JJ
results  ||| S:1876 E:1884 ||| NNS
could  ||| S:1884 E:1890 ||| MD
demonstrate  ||| S:1890 E:1902 ||| VB
correlations  ||| S:1902 E:1915 ||| VBN
between  ||| S:1915 E:1923 ||| IN
thyroid  ||| S:1923 E:1931 ||| JJ
hormones  ||| S:1931 E:1940 ||| NNS
and  ||| S:1940 E:1944 ||| CC
β-endorphin  ||| S:1944 E:1956 ||| JJ
response  ||| S:1956 E:1965 ||| NN
to  ||| S:1965 E:1968 ||| TO
showjumping ||| S:1968 E:1979 ||| VB
,  ||| S:1979 E:1981 ||| ,
although  ||| S:1981 E:1990 ||| IN
no  ||| S:1990 E:1993 ||| DT
definitive  ||| S:1993 E:2004 ||| JJ
conclusion  ||| S:2004 E:2015 ||| NN
can  ||| S:2015 E:2019 ||| MD
be  ||| S:2019 E:2022 ||| VB
produced  ||| S:2022 E:2031 ||| VBN
concerning  ||| S:2031 E:2042 ||| VBG
the  ||| S:2042 E:2046 ||| DT
relationships  ||| S:2046 E:2060 ||| NNS
between  ||| S:2060 E:2068 ||| IN
HPA  ||| S:2068 E:2072 ||| NNP
and  ||| S:2072 E:2076 ||| CC
thyroid  ||| S:2076 E:2084 ||| JJ
function  ||| S:2084 E:2093 ||| NN
during  ||| S:2093 E:2100 ||| IN
exercise ||| S:2100 E:2108 ||| NN
.  ||| S:2108 E:2110 ||| .
